Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy

BACKGROUND: Combination chemotherapy uses drugs that target different cancer hallmarks, resulting in synergistic or additive toxicity. This strategy enhances therapeutic efficacy as well as minimizes drug resistance and side effects. In this study, we investigated whether silver nanoparticles act as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rank Miranda, Renata, Pereira da Fonseca, Micaella, Korzeniowska, Barbara, Skytte, Lilian, Lund Rasmussen, Kaare, Kjeldsen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654574/
https://www.ncbi.nlm.nih.gov/pubmed/33168016
http://dx.doi.org/10.1186/s12951-020-00719-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654574/
https://www.ncbi.nlm.nih.gov/pubmed/33168016
http://dx.doi.org/10.1186/s12951-020-00719-x

Ejemplares similares